insulin resistance/carbohydrate

CROSS-REFERENCE TO RELATED APPLICATIONS Related subject matter is disclosed in a U.S. patent application of Gordon et al, entitled "A System and Method for Integrating Data with Guidelines to Generate Displays Containing the Guidelines and Data", Ser. No. 09/985,173, filed Nov. 1, 2001; and in a

TECHNICAL FIELD The present invention relates to the prevention and treatment of carbohydrate and/or fat metabolism disorders in humans and animals. BACKGROUND OF THE INVENTION Type 2 diabetes, the most common form of diabetes, is a chronic, progressive metabolic disease. It is characterized by

FIELD OF THE INVENTION The invention relates to a carbohydrate fraction that gives a sustained and lower glucose release after consumption. BACKGROUND OF THE INVENTION Glucose is an important source of energy to the cells in the human body and is abundantly present in food ingredients. After

FIELD OF THE INVENTION The invention relates to a carbohydrate fraction that gives a sustained and lower glucose release after consumption. BACKGROUND OF THE INVENTION Glucose is an important source of energy to the cells in the human body and is abundantly present in food ingredients. After

FIELD OF THE INVENTION A method and a device for sustained medical infusion of therapeutic fluids to patients is described. Some aspects relate to portable infusion devices and to a method for infusion that includes administering a therapeutic fluid to the patient after assessing a diabetic state of

FIELD OF THE INVENTION The invention relates to a carbohydrate fraction that gives a sustained and lower glucose release after consumption. BACKGROUND OF THE INVENTION Glucose is an important source of energy to the cells in the human body and abundantly present in food ingredients. After

BACKGROUND 1. Technical Field The present invention relates generally to nutrition and more particularly to a method and nutritional composition for improving glucose and insulin balance in an individual. In one embodiment, the invention provides a nutritional composition having a

TECHNICAL FIELD The present invention relates to a method for predicting the glucose concentration of a subject and recommending therapeutic action. BACKGROUND In the United States, approximately three million people have type 1 diabetes..sup.[1] To treat their condition, these patients depend

TECHNICAL FIELD The present invention relates to a method for diagnosing or monitoring carbohydrate metabolism disorders by assaying adiponectin (GBP28) in a sample, a method for monitoring the therapeutic effects of agents for type II diabetes by assaying GBP28 in a sample, a method for assaying

STATEMENT REGARDING FEDERALLY-SPONSORED R&D Not applicable REFERENCE TO MICROFICHE APPENDIX Not applicable FIELD OF THE INVENTION The invention is directed to the field of transgenic mice containing a disrupted PTP-1B gene. The mice may contain a disruption in either one or both copies of the

FIELD OF INVENTION The present invention relates to infant formulas and methods for using the formulas in feeding newborn infants. BACKGROUND OF THE INVENTION There are many different infant nutritional formulas that are commercially available or otherwise known in the infant formula art. These

FIELD OF INVENTION The present invention relates to infant formulas and methods for using the formulas in feeding newborn infants. BACKGROUND OF THE INVENTION There are many different infant nutritional formulas that are commercially available or otherwise known in the infant formula art. These

TECHNICAL FIELD The present invention relates generally to an integrated diabetes management system, and more particularly, to the use of exogenous data to predict alarms and to manage glucose levels. BACKGROUND Glucose monitoring systems for patients afflicted with diabetes may incorporate various

RELATED APPLICATIONS This is a continuation-in-part of application Ser. No. 463,327 filed Jan. 10, 1990, abandoned, which in turn is a continuation-in-part of application Ser. No. 192,332, filed May 10, 1988; both by Albert H. Meier and Anthony H. Cincotta respectively. Both applications are titled

1. FIELD OF THE INVENTION This invention relates to a process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose. In